The company manufactures and sells dry cell batteries, including zinc-carbon, alkaline, and lithium coin varieties, primarily for household electronics and portable appliances in the Indian market.
The company possesses a narrow moat based on the Panasonic brand and a wide distribution network, but this is contradicted by low net margins (3.3%) and negative EPS growth, suggesting a lack of durable pricing power against low-cost imports.
Management maintains a debt-free balance sheet and pays regular dividends, but reinvestment has failed to generate meaningful growth, evidenced by a 2.1% revenue CAGR and declining earnings over the period.
The company's demise was driven by a toxic combination of stagnant growth and unquantified regulatory liabilities. While management sat on a debt-free balance sheet, they failed to innovate or defend against low-cost competitors, leading to a continued slide in earnings. The 'Panasonic' brand proved insufficient to maintain pricing power as margins remained razor-thin. Ultimately, the unaddressed environmental liabilities from the Battery Waste Management Rules materialized into massive fines, wiping out years of accumulated dividends and forcing a fire sale of assets that were already legally clouded by improper title deeds.
RichFakir rates Panasonic Energy India Company Ltd's business quality as poor — 33/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as narrow.
On our model, Panasonic Energy India Company Ltd is trading far above our estimate of fair value (expensive on our lens); we rate its price expensive. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Panasonic Energy India Company Ltd is: Avoid. We are steering clear of this one — the red flags below outweigh anything the price or numbers offer.
RichFakir's educational estimate of Panasonic Energy India Company Ltd's fair value is about ₹75 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →